FORMAN ERIC (Secretary) purchased 27.3% of their position (21.06K shares) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $11.7K — a significant purchase. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 11/21/2022ACC: 0001493152-22-033084
Officer· Secretary
Since Dec 2020
+21.06K
Net shares
Net buyer
$11.7K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
21.06K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+4.85K
Price / share
$0.54
Trade value
$2.62K
% of position
6.3%
11/17/2022
77.08K→81.94K
Common Stock
Indirect
Shares
+7.65K
Price / share
$0.57
Trade value
$4.34K
% of position
9.3%
11/18/2022
81.94K→89.58K
Common Stock
Indirect
Shares
+2.50K
Price / share
$0.56
Trade value
$1.40K
% of position
2.8%
11/18/2022
89.58K→92.08K
Common Stock
Indirect
Shares
+6.06K
Price / share
$0.56
Trade value
$3.39K
% of position
6.6%
11/18/2022
92.08K→98.14K
Total
Net shares
+21.06K
Net value
$11.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/17/2022 | P · Purchase | +4.85K | $0.54 | $2.62K | 6.3% | 77.08K | 81.94K |
| Common Stock Indirect | 11/18/2022 | P · Purchase | +7.65K | $0.57 | $4.34K | 9.3% | 81.94K | 89.58K |
| Common Stock Indirect | 11/18/2022 | P · Purchase | +2.50K | $0.56 | $1.40K | 2.8% | 89.58K | 92.08K |
| Common Stock Indirect | 11/18/2022 | P · Purchase | +6.06K | $0.56 | $3.39K | 6.6% | 92.08K | 98.14K |
| Total | +21.06K | $11.74K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned38.60K
Total
38.60K direct38.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 38.60K | Direct |
| Total | 38.60K | 38.60K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported